Overexpression of S6 kinase 1 in brain tumours is associated with induction of hypoxia-responsive genes and predicts patients' survival

Journal of Oncology

Volumn , Issue , 2012, Pages

  Ismail, Heba M S ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN; PROTEIN NEDD9; S6 KINASE; TRANSCRIPTION FACTOR SOX4; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ARTICLE; BRAIN TUMOR; CANCER SURVIVAL; DATA BASE; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE OVEREXPRESSION; HUMAN; PREDICTOR VARIABLE;

EID: 84861090959     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/416927     Document Type: Article

References (49)

1. Russell D. S., Rubenstein L. J., Pathology of Tumours of the Nervous System 1989 5th Baltimore, Md, USA Williams Wilkins
2. Kaderali Z., Lamberti-Pasculli M., Rutka J. T., The changing epidemiology of paediatric brain tumours: a review from the hospital for sick children Child's Nervous System 2009 25 7 787 793
3. Ohgaki H., Kleihues P., Epidemiology and etiolog (Pubitemid 40287792)
4. Porter K. R., McCarthy B. J., Freels S., Kim Y., Davis F. G., Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology Neuro-Oncology 2010 12 6 520 527
5. McCarthy B. J., Schellinger K. A., Propp J. M., Kruchko C., Malmer B., A case for the worldwide collection of primary benign brain tumors Neuroepidemiology 2009 33 3 268 275
6. Inskip P. D., Ron E., Brain and Other Central Nervous System Cancer 2002 chapter 12 Middle East Cancer Consortium. http://seer.cancer.gov/publications/ mecc/meccbrain.pdf
7. Omuro A. M., Faivre S., Raymond E., Lessons learned in the development of targeted therapy for malignant gliomas Molecular Cancer Therapeutics 2007 6 7 1909 1919 (Pubitemid 47052481)
8. Vivanco I., Sawyers C. L., The phosphatidylinositol 3-kinase-AKT pathway in human cancer Nature Reviews Cancer 2002 2 7 489 501 (Pubitemid 37328931)
9. Wong A. J., Bigner S. H., Bigner D. D., Kinzler K. W., Hamilton S. R., Vogelstein B., Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification Proceedings of the National Academy of Sciences of the United States of America 1987 84 19 6899 6903
10. Ohgaki H., Genetic pathways to glioblastomas Neuropathology 2005 25 1 1 7 (Pubitemid 40477707)
11. Choe G., Horvath S., Cloughesy T. F., Crosby K., Seligson D., Palotie A., Inge L., Smith B. L., Sawyers C. L., Mischel P. S., Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo Cancer Research 2003 63 11 2742 2746 (Pubitemid 36667143)
12. Chakravarti A., Zhai G., Suzuki Y., Sarkesh S., Black P. M., Muzikansky A., Loeffler J. S., The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas Journal of Clinical Oncology 2004 22 10 1926 1933 (Pubitemid 41095185)
13. Hay N., Sonenberg N., Upstream and downstream of mTOR Genes and Development 2004 18 16 1926 1945 (Pubitemid 39071573)
14. Kaper F., Dornhoefer N., Giaccia A. J., Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions Cancer Research 2006 66 3 1561 1569 (Pubitemid 43259938)
15. Bjornsti M. A., Houghton P. J., The TOR pathway: a target for cancer therapy Nature Reviews Cancer 2004 4 5 335 348 (Pubitemid 38579480)
16. Huang S., Houghton P. J., Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic Current Opinion in Investigational Drugs 2002 3 2 295 304 (Pubitemid 34456089)
17. Chen J., Fang Y., A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling Biochemical Pharmacology 2002 64 7 1071 1077 (Pubitemid 35247814)
18. Wei L. H., Su H., Hildebrandt I. J., Phelps M. E., Czernin J., Weber W. A., Changes in tumor metabolism as readout for mammalian target of rapamycin kinase inhibition by rapamycin in glioblastoma Clinical Cancer Research 2008 14 11 3416 3426
19. Reardon D. A., Desjardins A., Vredenburgh J. J., Gururangan S., Friedman A. H., Herndon J. E., Marcello J., Norfleet J. A., McLendon R. E., Sampson J. H., Friedman H. S., Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma Journal of Neuro-Oncology 2010 96 2 219 230
20. Yu K., Toral-Barza L., Discafani C., Zhang W. G., Skotnicki J., Frost P., Gibbons J. J., mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer Endocrine-Related Cancer 2001 8 3 249 258 (Pubitemid 32947647)
21. Dutcher J. P., Motzer R. J., Atkins M. B., Figlin R. A., Kaelin W. G., Stadler W. M., Gordon M. S., George D. J., Mammalian target of rapamycin inhibition Clinical Cancer Research 2004 10 18 6382S 6387S (Pubitemid 39287496)
22. Gao N., Zhang Z., Jiang B. H., Shi X., Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer Biochemical and Biophysical Research Communications 2003 310 4 1124 1132 (Pubitemid 37237653)
23. Galanis E., Buckner J. C., Maurer M. J., Kreisberg J. I., Ballman K., Boni J., Peralba J. M., Jenkins R. B., Dakhil S. R., Morton R. F., Jaeckle K. A., Scheithauer B. W., Dancey J., Hidalgo M., Walsh D. J., Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a north central cancer treatment group study Journal of Clinical Oncology 2005 23 23 5294 5304 (Pubitemid 46206983)
24. Nakamura J. L., Garcia E., Pieper R. O., S6K1 plays a key role in glial transformation Cancer Research 2008 68 16 6516 6523
25. Jastrzebski K., Hannan K. M., Tchoubrieva E. B., Hannan R. D., Pearson R. B., Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function Growth Factors 2007 25 4 209 226
26. Rhodes D. R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., Barrette T., Pandey A., Chinnaiyan A. M., ONCOMINE: a Cancer microarray database and integrated data-mining platform Neoplasia 2004 6 1 1 6 (Pubitemid 38391943)
27. French P. J., Swagemakers S. M., Nagel J. H., Kouwenhoven M. C. M., Brouwer E., Van Spek P. D., Luider T. M., Kros J. M., Van Den Bent M. J., Smitt P. A. S., Gene expression profiles associated with treatment response in oligodendrogliomas Cancer Research 2005 65 24 11335 11344 (Pubitemid 41821690)
28. Pomeroy S. L., Tamayo P., Gaasenbeek M., Sturla L. M., Angelo M., McLaughlin M. E., Kim J. Y. H., Goumnerova L. C., Black P. M., Lau C., Allen J. C., Zagzag D., Olson J. M., Curran T., Wetmore C., Biegel J. A., Poggio T., Mukherjee S., Rifkin R., Califano A., Stolovitzky G., Louis D. N., Mesirov J. P., Lander E. S., Golub T. R., Prediction of central nervous system embryonal tumour outcome based on gene expression Nature 2002 415 6870 436 442 (Pubitemid 34100955)
29. Nutt C. L., Mani D. R., Betensky R. A., Tamayo P., Cairncross J. G., Ladd C., Pohl U., Hartmann C., McLaughlin M. E., Batchelor T. T., Black P. M., Von Deimling A., Pomeroy S. L., Golub T. R., Louis D. N., Gene expression-based classification of malignant gliomas correlates better with survival than histological classification Cancer Research 2003 63 7 1602 1607 (Pubitemid 36373650)
30. Fhling M., Cellular oxygen sensing, signalling and how to survive translational arrest in hypoxia Acta Physiologica 2009 195 2 205 230
31. Land S. C., Tee A. R., Hypoxia-inducible factor 1 is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif The Journal of Biological Chemistry 2007 282 28 20534 20543 (Pubitemid 47100043)
32. Li W., Tan D., Zhang Z., Liang J. J., Brown R. E., Activation of Akt-mTOR-p70S6K pathway in angiogenesis in hepatocellular carcinoma Oncology Reports 2008 20 4 713 719
33. Liu L., Cash T. P., Jones R. G., Keith B., Thompson C. B., Simon M. C., Hypoxia-induced energy stress regulates mRNA translation and cell growth Molecular Cell 2006 21 4 521 531 (Pubitemid 43228007)
34. Brugarolas J., Lei K., Hurley R. L., Manning B. D., Reiling J. H., Hafen E., Witters L. A., Ellisen L. W., Kaelin W. G., Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex Genes and Development 2004 18 23 2893 2904 (Pubitemid 39602308)
35. Bernardi R., Guernah I., Jin D., Grisendi S., Alimonti A., Teruya-Feldstein J., Cordon-Cardo C., Celeste Simon M., Rafii S., Pandolfi P. P., PML inhibits HIF-1 translation and neoangiogenesis through repression of mTOR Nature 2006 442 7104 779 785 (Pubitemid 44258904)
36. Sun L., Hui A. M., Su Q., Vortmeyer A., Kotliarov Y., Pastorino S., Passaniti A., Menon J., Walling J., Bailey R., Rosenblum M., Mikkelsen T., Fine H. A., Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain Cancer Cell 2006 9 4 287 300
37. Shai R., Shi T., Kremen T. J., Horvath S., Liau L. M., Cloughesy T. F., Mischel P. S., Nelson S. F., Gene expression profiling identifies molecular subtypes of gliomas Oncogene 2003 22 31 4918 4923 (Pubitemid 36981282)
38. Rickman D. S., Bobek M. P., Misek D. E., Kuick R., Blaivas M., Kurnit D. M., Taylor J., Hanash S. M., Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis Cancer Research 2001 61 18 6885 6891 (Pubitemid 32896514)
39. Bredel M., Bredel C., Juric D., Harsh G. R., Vogel H., Recht L. D., Sikic B. I., Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas Cancer Research 2005 65 19 8679 8689 (Pubitemid 41377355)
40. Liang Y., Diehn M., Watson N., Bollen A. W., Aldape K. D., Nicholas M. K., Lamborn K. R., Berger M. S., Botstein D., Brown P. O., Israel M. A., Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme Proceedings of the National Academy of Sciences of the United States of America 2005 102 16 5814 5819 (Pubitemid 40559642)
41. Gutmann D. H., Hedrick N. M., Li J., Nagarajan R., Perry A., Watson M. A., Comparative gene expression profile analysis of neurofibromatosis 1-associated and sporadic pilocytic astrocytomas Cancer Research 2002 62 7 2085 2091 (Pubitemid 34408456)
42. van den Boom J., Wolter M., Kuick R., Misek D. E., Youkilis A. S., Wechsler D. S., Sommer C., Reifenberger G., Hanash S. M., Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction American Journal of Pathology 2003 163 3 1033 1043 (Pubitemid 37040139)
43. Murat A., Migliavacca E., Gorlia T., Lambiv W. L., Shay T., Hamou M. F., De Tribolet N., Regli L., Wick W., Kouwenhoven M. C. M., Hainfellner J. A., Heppner F. L., Dietrich P. Y., Zimmer Y., Cairncross J. G., Janzer R. C., Domany E., Delorenzi M., Stupp R., Hegi M. E., Stem cell-related self-renewal signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma Journal of Clinical Oncology 2008 26 18 3015 3024
44. Brugge J., Hung M. C., Mills G. B., A new mutational aktivation in the PI3K pathway Cancer Cell 2007 12 2 104 107 (Pubitemid 47199129)
45. Barlund M., Forozan F., Kononen J., Bubendorf L., Chen Y., Bittner M. L., Torhorst J., Haas P., Bucher C., Sauter G., Kallioniemi O. P., Kallioniemi A., Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis Journal of the National Cancer Institute 2000 92 15 1252 1259 (Pubitemid 30627733)
46. Couch F. J., Wang X. Y., Wu G. J., Qian J., Jenkins R. B., James C. D., Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer Cancer Research 1999 59 7 1408 1411 (Pubitemid 29160100)
47. Monni O., Barlund M., Mousses S., Kononen J., Sauter G., Heiskanen M., Paavola P., Avela K., Chen Y., Bittner M. L., Kallioniemi A., Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer Proceedings of the National Academy of Sciences of the United States of America 2001 98 10 5711 5716 (Pubitemid 32435707)
48. Wu G. J., Sinclair C. S., Paape J., Ingle J. N., Roche P. C., David James C., Couch F. J., 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGMA1B genes Cancer Research 2000 60 19 5371 5375
49. Nordgren I. K., Tavassoli A., Targeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor Chemical Society Reviews 2011 40 8 4307 4317